Free Trial
NASDAQ:JMAC

Maxpro Capital Acquisition (JMAC) Stock Price, News & Analysis

Maxpro Capital Acquisition logo
$5.88 -0.03 (-0.51%)
As of 04/22/2025

About Maxpro Capital Acquisition Stock (NASDAQ:JMAC)

Key Stats

Today's Range
$5.41
$6.09
50-Day Range
$5.15
$10.39
52-Week Range
$7.50
$19.22
Volume
12,281 shs
Average Volume
74,040 shs
Market Capitalization
$78.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Maxpro Capital Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Taipei City, Taiwan.

Receive JMAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Maxpro Capital Acquisition and its competitors with MarketBeat's FREE daily newsletter.

JMAC Stock News Headlines

Two Unmistakable Patterns Return…
The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at record pace. Why massive amounts of gold are being moved between countries. Why governments are repositioning their gold reserves. But here's what most people miss, the second pattern: During these resets, a unique anomaly appears in certain gold mining stocks. I call it the "Golden Anomaly."
Maxpro Capital Acquisition Corp
See More Headlines

JMAC Stock Analysis - Frequently Asked Questions

Maxpro Capital Acquisition's stock was trading at $9.75 at the beginning of 2025. Since then, JMAC stock has decreased by 39.7% and is now trading at $5.88.
View the best growth stocks for 2025 here
.

Shares of JMAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Maxpro Capital Acquisition investors own include Meta Platforms (META), PhaseBio Pharmaceuticals (PHAS), Dermata Therapeutics (DRMA), Daifuku (DAIUF), CXApp (CXAI), Centogene (CNTG) and China Jo-Jo Drugstores (CJJD).

Company Calendar

Today
4/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Holding & other investment offices
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:JMAC
Web
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
10,840,000
Market Cap
$78.96 million
Optionable
Not Optionable
Beta
0.01
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:JMAC) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners